Resveratrol vs Pterostilbene: How They Actually Work and What the Evidence Says
Both compounds activate overlapping longevity pathways, but they are not interchangeable. Pterostilbene is structurally similar to resveratrol yet meaningfully different in how the body processes and uses it.
The Mechanism (Skip This If You Just Want the Dose)
Resveratrol is a polyphenol produced by plants under stress. Its primary longevity-relevant action runs through sirtuin activation, specifically SIRT1, a NAD+-dependent deacetylase that regulates gene expression tied to metabolic efficiency, DNA repair, and cellular stress response. SIRT1 activity influences the AMPK pathway, which signals low-energy states and promotes mitochondrial biogenesis. Resveratrol also modulates the mTOR pathway by indirectly reducing mTORC1 activity, which is associated with slower cellular aging in animal models.
Pterostilbene is a dimethylated ether analog of resveratrol. Two hydroxyl groups on resveratrol are replaced with methoxy groups. That structural change is not cosmetic. It dramatically increases lipophilicity, meaning pterostilbene crosses cell membranes more readily and resists hepatic first-pass metabolism more effectively. Oral bioavailability studies in animal models suggest pterostilbene reaches systemic circulation at roughly 80% bioavailability compared to resveratrol's estimated 20–40%, though human data on this comparison is still limited.
Both compounds also interact with the NF-kB inflammatory signaling pathway, suppressing pro-inflammatory cytokine expression. Pterostilbene shows stronger affinity for PPAR-alpha, a nuclear receptor involved in fatty acid oxidation and lipid metabolism. Resveratrol has a broader but shallower receptor interaction profile. Think of it this way: resveratrol casts a wider net, pterostilbene hits fewer targets but with more precision and durability.
What the Clinical Evidence Actually Shows
Human clinical trials on both compounds are still relatively early-stage. Most mechanistic data comes from in vitro and rodent studies. That context matters before reading any finding below.
| Study Type | Sample Size | Finding | Dose Used |
|---|---|---|---|
| Resveratrol RCT (obese adults, 2012) | 11 participants | Improved mitochondrial function, reduced blood glucose and triglycerides | 150 mg/day |
| Pterostilbene RCT (hypercholesterolemia, 2014) | 80 participants | Reduced LDL cholesterol by up to 14 mg/dL at higher dose | 125 mg twice daily |
| Resveratrol meta-analysis (2020, Nutrients) | 17 trials reviewed | Modest reductions in fasting glucose and systolic blood pressure | 150–500 mg/day |
| Pterostilbene animal study (cognitive aging) | N/A (rodent model) | Reversed age-related cognitive decline markers in hippocampal tissue | Variable |
| Resveratrol + exercise RCT (2013, Journal of Physiology) | 27 older men | Resveratrol blunted some cardiovascular adaptations from exercise | 250 mg/day |
That 2013 finding from the Journal of Physiology is worth pausing on. Resveratrol at 250 mg/day appeared to reduce exercise-induced improvements in VO2 max and blood pressure in older men. The proposed mechanism involves resveratrol's antioxidant activity interfering with the reactive oxygen species signaling that drives beneficial cardiovascular adaptations. This does not mean resveratrol is harmful, but it does suggest timing and context around exercise matter.
For a deeper look at how resveratrol is formulated for daily use, see Elm & Rye's resveratrol supplement and the sourcing decisions behind it.
How to Take It Correctly
Dosing strategy differs between the two compounds because of their metabolic fates.
Resveratrol:
- Typical clinical dose range: 150–500 mg/day
- Take with a fat-containing meal to improve absorption
- Trans-resveratrol is the biologically active form. Avoid products that do not specify isomer
- Avoid taking within 1–2 hours of intense exercise if cardiovascular adaptation is your goal
- Some practitioners split doses (morning and evening) to maintain plasma levels, though half-life data does not strongly support this for most users
Pterostilbene:
- Typical clinical dose range: 50–250 mg/day
- Higher bioavailability means lower doses may achieve comparable tissue concentrations
- Can be taken with or without food due to its lipophilic nature
- Pterostilbene is often paired with resveratrol in longevity stacks because the two compounds have partially overlapping but distinct receptor targets
- At doses above 250 mg/day, some trials have noted modest increases in LDL cholesterol. Stay within the studied range
My take: For the Elm & Rye resveratrol formula, I specifically look for trans-resveratrol standardized to a minimum of 98% purity rather than whole-grape extract blends, because the active isomer concentration in blended extracts varies too widely to dose reliably. That standardization is the difference between a product that works and one that looks good on a label.
If you are interested in how polyphenols like fisetin interact with similar cellular aging pathways, the Elm & Rye fisetin supplement covers a related but mechanistically distinct senolytic approach worth reading about.
The Honest Limitations
The longevity evidence for both compounds in humans is preliminary. Most of the sirtuin-activation and lifespan-extension data comes from yeast, worms, and mice. Translating that to human aging outcomes requires decades of longitudinal data that does not yet exist.
Individual response varies considerably. CYP1A1 and CYP1B1 enzyme activity, which governs how quickly these compounds are metabolized, differs between people. Someone who metabolizes resveratrol rapidly may see minimal plasma exposure at standard doses. There is no practical clinical test for this outside of a research setting.
Resveratrol has known interactions with CYP3A4-metabolized medications, including certain statins, blood thinners, and immunosuppressants. If you take any of those, talk to a physician before adding resveratrol or pterostilbene. Both compounds have mild antiplatelet activity, which compounds the risk with anticoagulants.
Pterostilbene's safety profile at high doses is less studied than resveratrol's. The LDL-raising signal at doses above 250 mg/day in the 2014 RCT has not been fully explained. Until more data exists, I would not recommend exceeding 250 mg/day without medical oversight.
Neither compound is a substitute for caloric discipline, sleep quality, or consistent physical training. The sirtuin and AMPK pathways these molecules target are the same pathways activated by fasting and aerobic exercise. Supplements work within the context of those inputs, not instead of them.
According to the NIH Office of Dietary Supplements, evidence for resveratrol's clinical benefits in humans remains inconsistent, and no recommended daily intake has been established.
The Bottom Line
Pterostilbene offers meaningfully higher bioavailability and more targeted receptor activity than resveratrol, making it the stronger candidate for cellular longevity pathways at lower doses. Resveratrol has a longer research history and broader studied applications, but context around exercise timing and medication interactions matters more than most supplement brands acknowledge.
FAQ
Is pterostilbene better than resveratrol for longevity?
Pterostilbene has higher estimated bioavailability and stronger PPAR-alpha activity, which may make it more efficient at reaching target tissues. However, resveratrol has a larger body of human clinical research, so "better" depends on what outcome you are optimizing for.
The two compounds are often used together in research protocols because their receptor interaction profiles partially complement each other. If choosing one, pterostilbene at 50–125 mg/day is a reasonable starting point for longevity-focused use.
Can I take resveratrol and pterostilbene together?
Yes, combining them is common in longevity supplement stacks and is generally considered safe within normal dose ranges. The combination targets overlapping pathways (SIRT1, AMPK) through slightly different mechanisms, which may produce additive effects.
Keep total daily doses within studied ranges: resveratrol at 150–500 mg and pterostilbene at 50–250 mg. If you take any CYP3A4-metabolized medications, consult a physician before stacking both.
When should I take resveratrol for best absorption?
Take resveratrol with a meal that contains dietary fat. Fat in the digestive tract improves polyphenol solubility and absorption through the intestinal wall. If you exercise for cardiovascular adaptation, consider taking it several hours away from your workout based on the 2013 Journal of Physiology findings on antioxidant interference with training adaptations.